Asiamedic Health Screening

Facebook-f Instagram
Investor Relation Menu

News

Proposed Renounceable Non-Underwritten Rights Issue Of Up To 1,561,952,500 New Ordinary Shares In The Capital Of The Company - Receipt Of Listing And Quotation Notice

BackDec 06, 2019
Announcement Title Intermediate Securities Distribution
Date & Time of Broadcast Dec 6, 2019 17:17
Status Replace
Corporate Action Reference SG191205RHDIVA9M
Submitted By (Co./ Ind. Name) Stanley Woo
Designation Group Financial Controller
Event Status Pending AIP/ LQN Announcement
Underwritten No
Shareholders' Approval Required? Yes
Shareholders' Approval Obtained No
Financial Year End 31/12/2018
Foreign Shareholder Eligibility No
Regulatory Outcome
Attachment For Regulatory Outcome  
AML_RightsIssue_LQN_20191205.pdf
Event Narrative
Narrative Type Narrative Text
Additional Text PROPOSED RENOUNCEABLE NON-UNDERWRITTEN RIGHTS ISSUE OF UP TO 1,561,952,500 NEW ORDINARY SHARES IN THE CAPITAL OF THE COMPANY - RECEIPT OF LISTING AND QUOTATION NOTICE
Dates
Rights Details
Rights Security ISIN SG0505000059
Rights Security Name ASIAMEDIC LIMITED
Security Not Found? No
Renounceable Yes
Rights Security Distribution Ratio- Underlying 1
Rights Security Distribution Ratio- Rights Security 4
 
Option Exercise
Issue Price (Per Rights) SGD 0.012
Disbursed Security
ISIN Name Security Type Distribution Ratio- Rights Distribution Ratio- Disbursed
SG0505000059 ASIAMEDIC LIMITED Ordinary Share 1 1
Renounceable Conditions
Allow Over Subscription Yes

Attachments

  1. Receipt Of LQN (Size: 25,346 bytes)
  2. Receipt Of LQN (Size: 25,346 bytes)